170 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Better Buy: Acadia Pharmaceuticals vs. Biogen https://www.fool.com/investing/2018/05/18/better-buy-acadia-pharmaceuticals-vs-biogen.aspx?source=iedfolrf0000001 May 18, 2018 - Which of these beaten-down biotech stocks is in better position to mount a strong comeback?
Acadia: Damn The Torpedoes, Full Speed Ahead https://seekingalpha.com/article/4170617-acadia-damn-torpedoes-full-speed-ahead?source=feed_sector_healthcare May 07, 2018 - Acadia - the setup.Acadia's pipeline in a word: pimavanserin.Acadia's stock price yo-yoed in April as NUPLAZID® safety concerns took center stage.Today's (5/4/18) earnings report and CC provide a posi
Why Acadia Pharmaceuticals Jumped 11% Higher Today https://www.fool.com/investing/2018/05/04/why-acadia-pharmaceuticals-jumped-11-higher-today.aspx?source=iedfolrf0000001 May 04, 2018 - First-quarter revenue growth has investors excited.
ACADIA Pharmaceuticals' (ACAD) CEO Steve Davis on Q1 2018 Results - Earnings Call Transcript https://seekingalpha.com/article/4170055-acadia-pharmaceuticals-acad-ceo-steve-davis-q1-2018-results-earnings-call-transcript?source=feed_sector_healthcare May 04, 2018 - ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q1 2018 Earnings Conference Call May 04, 2018 8:30 AM ET Executives Elena Ridloff – Senior Vice President-Investor Relations Steve Davis – President and Chief
ACADIA Posts Narrower than Expected Loss in Q1, Sales Beat http://www.zacks.com/stock/news/302361/acadia-posts-narrower-than-expected-loss-in-q1-sales-beat?cid=CS-ZC--302361 May 04, 2018 - ACADIA posted narrower than expected loss in the first quarter of 2018 and sales beat estimates.
Will ACADIA (ACAD) Disappoint Investors This Earnings Season? http://www.zacks.com/stock/news/301727/will-acadia-acad-disappoint-investors-this-earnings-season?cid=CS-ZC-FT-301727 May 01, 2018 - ACADIA (ACAD) is expected to release first-quarter 2018 results on May 8 and provide updates on its drug, Nuplazid.
Biotech Analysis Central Pharma News: AstraZeneca's Fumble, Acadia's Nuplazid Review, Catabasis' Second Success In DMD https://seekingalpha.com/article/4166661-biotech-analysis-central-pharma-news-astrazenecas-fumble-acadias-nuplazid-review-catabasis?source=feed_sector_healthcare Apr 26, 2018 - AstraZeneca suffers setback in latest lung-cancer combination study.FDA announces safety review of Nuplazid from Acadia Pharmaceuticals.Catabasis highlights new positive data for edasalonexent treatin
This Explains Why Acadia Pharmaceuticals Is Selling Off Today https://www.fool.com/investing/2018/04/25/this-explains-why-acadia-pharmaceuticals-is-droppi.aspx?source=iedfolrf0000001 Apr 25, 2018 - Shares tumble after a major news outlet reports that the FDA is re-examining the safety profile of Acadia's drug Nuplazid. Here's what investors need to know.
Institutional Top Ideas Series: Baker Brothers https://seekingalpha.com/article/4165526-institutional-top-ideas-series-baker-brothers?source=feed_sector_healthcare Apr 25, 2018 - Today's fund in the spotlight, Baker Brothers, has been struggling of late but as long term investors they´ve chalked up an impressive track record.I provide a brief overview of this fund and remind r
International Paper Is A Buy At Current Prices - Cramer's Lightning Round (4/19/18) https://seekingalpha.com/article/4164296-international-paper-buy-current-prices-cramers-lightning-round-4-19-18?source=feed_tag_cramers_picks Apr 20, 2018 - J.B. Hunt is a Buy.GrubHub has received a host of downgrades.Cramer prefers T-Mobile over Sprint.

Pages: 123456...17

Page 1>
DeepLinks for ACADIA Pharmaceuticals
ACAD - Google Finance https://www.google.com/finance?q=ACAD Industry related info and international coverage Summary News
ACAD - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=ACAD Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options